Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Organ-on-a-Chip, Tissue-on-a-Chip & Organoids Europe 2020

Torsten Hoffmann's Biography



Torsten Hoffmann, Senior Vice President Drug Discovery, Hesperos

Since more than 20 years in pharmaceutical R&D. Inventor of anti-emetic medicine Netupitant, FDA approved as Akynzeo in 2014, and since 2015 recommended by the National Comprehensive Cancer Network for preferred use. At Roche, created new R&D department and delivered later 52 new lead series into lead optimization, 32 small molecules into regulatory Tox studies, and more than 25 NCEs into clinical studies over 8 years. Over past 6 years in leading roles and as Scientific Advisory Board member in the European biotechnology industry, successfully prioritized and advanced strong R&D portfolios, and implemented novel approaches to encourage and enable innovation. Authored more than 95 publications, patent applications and published conference reports.

Torsten Hoffmann Image

Agenda is not currently available
Add to Calendar ▼2020-06-23 00:00:002020-06-24 00:00:00Europe/LondonOrgan-on-a-Chip, Tissue-on-a-Chip and Organoids Europe 2020Organ-on-a-Chip, Tissue-on-a-Chip and Organoids Europe 2020 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com